Meipeng Zhu

570 total citations · 1 hit paper
21 papers, 359 citations indexed

About

Meipeng Zhu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Meipeng Zhu has authored 21 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Meipeng Zhu's work include Bone Metabolism and Diseases (9 papers), Bone health and treatments (4 papers) and Bone and Joint Diseases (3 papers). Meipeng Zhu is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Bone health and treatments (4 papers) and Bone and Joint Diseases (3 papers). Meipeng Zhu collaborates with scholars based in China and United States. Meipeng Zhu's co-authors include Yimin Dong, Kehan Song, Honglei Kang, Renpeng Peng, Qian Guo, Feng Li, Hanfeng Guan, Yayun Zhang, Dawei Ye and Pengju Wang and has published in prestigious journals such as Cell Metabolism, The FASEB Journal and ACS Applied Materials & Interfaces.

In The Last Decade

Meipeng Zhu

19 papers receiving 358 citations

Hit Papers

A clinical-stage Nrf2 activator suppresses osteoclast dif... 2024 2026 2025 2024 10 20 30 40
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis
    2024 48 citations Yimin Dong, Honglei Kang et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meipeng Zhu China 11 170 77 66 63 56 21 359
Sheji Weng China 15 272 1.6× 90 1.2× 110 1.7× 74 1.2× 53 0.9× 23 566
Binqing Yu China 9 145 0.9× 60 0.8× 31 0.5× 66 1.0× 60 1.1× 10 310
Ken Ishitani Japan 15 107 0.6× 89 1.2× 32 0.5× 86 1.4× 65 1.2× 30 498
Junjie Niu China 10 181 1.1× 60 0.8× 22 0.3× 50 0.8× 52 0.9× 26 358
Hongfei Shi China 10 173 1.0× 89 1.2× 34 0.5× 55 0.9× 21 0.4× 22 464
Sheng Zhu China 10 134 0.8× 97 1.3× 50 0.8× 53 0.8× 16 0.3× 20 315
Huilin Yang China 10 176 1.0× 44 0.6× 26 0.4× 53 0.8× 31 0.6× 13 360
Lige Song China 10 351 2.1× 105 1.4× 47 0.7× 40 0.6× 39 0.7× 20 564
Irene Falsetti Italy 8 157 0.9× 67 0.9× 30 0.5× 17 0.3× 59 1.1× 21 325
Yanqing Sun China 11 113 0.7× 27 0.4× 34 0.5× 88 1.4× 48 0.9× 40 325

Countries citing papers authored by Meipeng Zhu

Since Specialization
Citations

This map shows the geographic impact of Meipeng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meipeng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meipeng Zhu more than expected).

Fields of papers citing papers by Meipeng Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meipeng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meipeng Zhu. The network helps show where Meipeng Zhu may publish in the future.

Co-authorship network of co-authors of Meipeng Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Meipeng Zhu. A scholar is included among the top collaborators of Meipeng Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meipeng Zhu. Meipeng Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jianwen, Yayun Zhang, Junhong Li, et al.. (2025). Blocking the LRH-1/LCN2 axis by ML-180, an LRH-1 inverse agonist, ameliorates osteoarthritis via inhibiting the MAPK pathway. Biochemical Pharmacology. 237. 116922–116922. 1 indexed citations
2.
3.
Peng, Renpeng, Yimin Dong, Meng Zheng, et al.. (2024). IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism. Cell Death and Disease. 15(2). 111–111. 20 indexed citations
4.
5.
Dong, Yimin, Honglei Kang, Renpeng Peng, et al.. (2024). A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis. Cell Metabolism. 36(8). 1679–1695.e6. 48 indexed citations breakdown →
6.
7.
Wang, Sibo, Qian Ren, Yi Dai, et al.. (2023). α-Mangostin Exhibits a Therapeutic Effect on Spinal Cystic Echinococcosis by Affecting Glutamine Metabolism. Antimicrobial Agents and Chemotherapy. 67(6). e0009823–e0009823. 2 indexed citations
8.
Zhang, Yayun, Ranyue Ren, Yimin Dong, et al.. (2023). CXCL chemokines-mediated communication between macrophages and BMSCs on titanium surface promotes osteogenesis via the actin cytoskeleton pathway. Materials Today Bio. 23. 100816–100816. 14 indexed citations
9.
10.
Peng, Renpeng, Yimin Dong, Honglei Kang, et al.. (2022). Identification of Genes with Altered Methylation in Osteoclast Differentiation and Its Roles in Osteoporosis. DNA and Cell Biology. 41(6). 575–589. 5 indexed citations
11.
Dong, Yimin, Kehan Song, Pengju Wang, et al.. (2022). Blocking the cytohesin-2/ARF1 axis by SecinH3 ameliorates osteoclast-induced bone loss via attenuating JNK-mediated IRE1 endoribonuclease activity. Pharmacological Research. 185. 106513–106513. 12 indexed citations
12.
Kang, Honglei, Yimin Dong, Haiyang Liu, et al.. (2022). Titania-Nanotube-Coated Titanium Substrates Promote Osteogenesis and Suppress Osteoclastogenesis via Integrin ανβ3. ACS Applied Bio Materials. 5(12). 5832–5843. 3 indexed citations
13.
Kang, Honglei, Yimin Dong, Renpeng Peng, et al.. (2022). Inhibition of IRE1 suppresses the catabolic effect of IL-1β on nucleus pulposus cell and prevents intervertebral disc degeneration in vivo. Biochemical Pharmacology. 197. 114932–114932. 25 indexed citations
14.
Dong, Yimin, Honglei Kang, Renpeng Peng, et al.. (2022). Global, Regional, and National Burden of Low Bone Mineral Density From 1990 to 2019: Results From the Global Burden of Disease Study 2019. Frontiers in Endocrinology. 13. 870905–870905. 36 indexed citations
15.
Zhu, Meipeng, Qian Guo, Honglei Kang, et al.. (2022). Inhibition of FAAH suppresses RANKL ‐induced osteoclastogenesis and attenuates ovariectomy‐induced bone loss partially through repressing the IL17 pathway. The FASEB Journal. 37(1). e22690–e22690. 6 indexed citations
16.
Liu, Hui, Dahu Qi, Yutong Gao, et al.. (2021). Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss. Frontiers in Cell and Developmental Biology. 9. 640867–640867. 8 indexed citations
17.
Dong, Yimin, Renpeng Peng, Honglei Kang, et al.. (2021). Global incidence, prevalence, and disability of vertebral fractures: a systematic analysis of the global burden of disease study 2019. The Spine Journal. 22(5). 857–868. 72 indexed citations
18.
Qi, Dahu, Hui Liu, Xuying Sun, et al.. (2021). Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss. Frontiers in Pharmacology. 11. 621110–621110. 7 indexed citations
19.
Zhu, Meipeng, Hui Liu, Kai Sun, et al.. (2019). Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss. Biomedicine & Pharmacotherapy. 123. 109769–109769. 21 indexed citations
20.
Liu, Hui, Yonghui Dong, Yutong Gao, et al.. (2018). Hesperetin suppresses RANKL‐induced osteoclastogenesis and ameliorates lipopolysaccharide‐induced bone loss. Journal of Cellular Physiology. 234(7). 11009–11022. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheji Weng Breakdown of academic impact, for papers by Binqing Yu Breakdown of academic impact, for papers by Ken Ishitani Breakdown of academic impact, for papers by Junjie Niu Breakdown of academic impact, for papers by Hongfei Shi Breakdown of academic impact, for papers by Sheng Zhu Breakdown of academic impact, for papers by Huilin Yang Breakdown of academic impact, for papers by Lige Song Breakdown of academic impact, for papers by Irene Falsetti Breakdown of academic impact, for papers by Yanqing Sun
Rankless by CCL
2026